咨询与建议

限定检索结果

文献类型

  • 10 篇 期刊文献

馆藏范围

  • 10 篇 电子文献
  • 0 种 纸本馆藏

日期分布

学科分类号

  • 6 篇 医学
    • 4 篇 临床医学
    • 2 篇 基础医学(可授医学...
    • 2 篇 药学(可授医学、理...
    • 1 篇 公共卫生与预防医...
  • 2 篇 理学
    • 2 篇 数学
    • 1 篇 系统科学
  • 2 篇 工学
    • 2 篇 计算机科学与技术...
    • 1 篇 生物医学工程(可授...
    • 1 篇 软件工程

主题

  • 1 篇 central subspace
  • 1 篇 mavorixafor
  • 1 篇 neutropenia
  • 1 篇 combined immunod...
  • 1 篇 lymphopenia
  • 1 篇 optimal design
  • 1 篇 phase i/ii clini...
  • 1 篇 errors in variab...
  • 1 篇 hernia
  • 1 篇 sufficientdimens...
  • 1 篇 expectation of c...
  • 1 篇 adaptive clinica...
  • 1 篇 thompson samplin...
  • 1 篇 multi-armed band...
  • 1 篇 diagnosis
  • 1 篇 primary immunode...
  • 1 篇 bayesian methods
  • 1 篇 whim syndrome
  • 1 篇 variable selecti...
  • 1 篇 noncompliance

机构

  • 2 篇 statistical meth...
  • 1 篇 biostatistics an...
  • 1 篇 medicine departm...
  • 1 篇 institut jules b...
  • 1 篇 translation dise...
  • 1 篇 peking union med...
  • 1 篇 department of bi...
  • 1 篇 bristol myers sq...
  • 1 篇 medicine and res...
  • 1 篇 real-world data ...
  • 1 篇 vice president c...
  • 1 篇 surgery dept. nt...
  • 1 篇 outcome research...
  • 1 篇 department of pe...
  • 1 篇 abbott nutrition...
  • 1 篇 medicine dept. h...
  • 1 篇 syneos health bi...
  • 1 篇 associate profes...
  • 1 篇 senior director ...
  • 1 篇 health economics...

作者

  • 1 篇 j. sparks
  • 1 篇 w. little
  • 1 篇 yandong wei
  • 1 篇 y-h. im
  • 1 篇 f. dalenc
  • 1 篇 hu yanping
  • 1 篇 h.l. gomez moren...
  • 1 篇 thai hoai-thu
  • 1 篇 a. fischer
  • 1 篇 chalermsri c.
  • 1 篇 laiteerapong a.
  • 1 篇 lijian pei
  • 1 篇 yan lv
  • 1 篇 yan tina
  • 1 篇 a. sonnenblick
  • 1 篇 wichansawakun s.
  • 1 篇 steiner deborah
  • 1 篇 xiting zhu
  • 1 篇 m. chaballa
  • 1 篇 tey s.l.

语言

  • 9 篇 英文
  • 1 篇 中文
检索条件"机构=Biostatistics and Statistical Programming"
10 条 记 录,以下是1-10 订阅
排序:
Dimension reduction with expectation of conditional difference
收藏 引用
statistical Theory and Related Fields 2023年 第3期7卷 188-201页
作者: Wenhui Sheng Qingcong Yuan Department of Mathematical and Statistical Sciences Marquette UniversityMilwaukeeWIUSA Biostatistics and Programming SanofiUSBridgewaterNJUSA
In this article,we introduce a flexible model-free approach to sufficient dimension reduction analysis using the expectation of conditional difference *** any strict conditions,such as linearity condition or constant ... 详细信息
来源: 评论
On some "disadvantages" of the population approach
收藏 引用
AAPS Journal 2005年 第2期7卷 E374-E382页
作者: Nedelman, Jerry R. Biostatistics and Statistical Programming Novartis Pharmaceuticals East Hanover NJ 07936 One Health Plaza United States
In a seminal article on population pharmacokinetic modeling, researchers demonstrated how means and variances of pharmacokinetic parameters for a patient population could be inferred from sparse data collected under c... 详细信息
来源: 评论
On multi-armed bandit designs for dose-finding clinical trials
The Journal of Machine Learning Research
收藏 引用
The Journal of Machine Learning Research 2021年 第1期22卷 686-723页
作者: Maryam Aziz Emilie Kaufmann Marie-Karelle Riviere Spotify NYC Univ. Lille CNRS Inria Centrale Lille UMR 9189 CRIStAL Lille France Statistical Methodology Group Biostatistics and Programming department Sanofi R&D Chilly-Mazarin France
We study the problem of finding the optimal dosage in early stage clinical trials through the multiarmed bandit lens. We advocate the use of the Thompson Sampling principle, a flexible algorithm that can accommodate d... 详细信息
来源: 评论
Bayesian dose-regimen assessment in early phase oncology incorporating pharmacokinetics and pharmacodynamics
arXiv
收藏 引用
arXiv 2020年
作者: Gerard, Emma Zohar, Sarah Thai, Hoai-Thu Lorenzato, Christelle Riviere, Marie-Karelle Ursino, Moreno Centre de Recherche des Cordeliers Sorbonne Université Inserm Université de Paris ParisF-75006 France Oncology biostatistics Biostatistics and Programming department Sanofi R&D Vitry-sur-Seine France Statistical Methodology Group Biostatistics and Programming department Sanofi R&D Chilly-Mazarin France Translation Disease Modeling Digital and Data Science Sanofi R&D Chilly-Mazarin France F-CRIN PARTNERS platform AP-HP Université de Paris Paris France
Phase I dose-finding trials in oncology seek to find the maximum tolerated dose (MTD) of a drug under a specific schedule. Evaluating drug-schedules aims at improving treatment safety while maintaining efficacy. Howev... 详细信息
来源: 评论
Ex utero intrapartum therapy in infants with congenital diaphragmatic hernia:a propensity score matching analysis
收藏 引用
World Journal of Pediatric Surgery 2022年 第4期5卷 267-274页
作者: Yunlong Zhao Ying Wang Chao Liu Yulin Jiang Yandong Wei Hua Meng Shan Jian Xiting Zhu Lijian Pei Xiaochen Bai Feng Feng Yan Lv Xiya Zhou Qingwei Qi Jingna Li Lishuang Ma Peking Union Medical College Graduate School BeijingChina Department of Neonatal Surgery Children’s Hospital of Capital Institute of PediatricsCapital Institute of PediatricsBeijingChina Department of Obstetrics Peking Union Medical College HospitalBeijingChina Department of Ultrasound Peking Union Medical College HospitalBeijingChina Department of Pediatrics Peking Union Medical College HospitalBeijingChina Department of Biostatistics and Statistical Programming Everest Clinical Research CorporationBeijingChina Department of Anesthesiology Peking Union Medical College HospitalBeijingChina Department of Pediatrics Beijing Obstetrics and Gynecology HospitalCapital Medical UniversityBeijingChina Department of Radiology Peking Union Medical College HospitalBeijingChina
Objective Previous studies have shown that ex utero intrapartum therapy(EXIT)is safe and feasible for newborns with congenital diaphragmatic hernia(CDH).This study reports our experience with EXIT in fetuses with CDH ... 详细信息
来源: 评论
2376. Incidence ofClostridioides difficileInfection Among United States Medicare Advantage Enrollees
收藏 引用
Open Forum Infectious Diseases 2019年 第SUPPLEMENT_2期6卷 S819–S820页
作者: Heinrich, Kirstin Emir, Birol Ivanova, Jasmina Zhou, Jingying Yu, Holly Health Economics and Outcomes Research Pfizer Inc. Collegeville Pennsylvania Biostatistics Pfizer Inc. New York New York Real-World Data and Analytics Pfizer Inc. New York New York Statistical Programming Pfizer Inc. New York New York Outcome Research Heath Economics Pfizer Inc. Collegeville Pennsylvania
BackgroundClostridioides difficileinfection (CDI) may be life-threatening, and individuals aged ≥ 65 years are at increased risk. CDI burden among Medicare fee-for-service enrollees and nursing home residents in the ...
来源: 评论
Effects of a specialized oral nutritional supplement with dietary counseling on nutritional outcomes in community-dwelling older adults at risk of malnutrition: A randomized controlled trial
收藏 引用
Clinical Nutrition ESPEN 2024年 63卷 1318-1318页
作者: Muangpaisan, W. Wichansawakun, S. Huynh, D.T.T. Intalapaporn, S. Chalermsri, C. Thititagul, O. Chupisanyarote, K. Chuansangeam, M. Laiteerapong, A. Yalawar, M. Huang, C. Tey, S.L. Liu, Z. Faculty of Medicine Siriraj Hospital Mahidol University Bangkok Faculty of Medicine Thammasat University Pathum Thani Thailand Abbott Nutrition Research and Development Asia-Pacific Center Singapore Singapore Thammasat University Hospital Pathum Thani Abbott Nutrition Research and Development Bangkok Thailand Biostatistics and Statistical Programming Cognizant Technologies Solution Pvt. Ltd Bangalore India Abbott Nutrition Research and Development Shanghai China
来源: 评论
7 Phase 3 Trial of an Oral CXCR4 Antagonist, Mavorixafor, for Treatment of Patients With WHIM Syndrome: Preliminary Results From Ongoing Open-Label Extension Period of Continuous Mavorixafor Treatment
收藏 引用
Clinical Immunology 2024年 262卷 109949-109949页
作者: Tarrant, Teresa Badolato, Raffaele Donadieu, Jean Dubuc, Susan Hu, Yanping Jiang, Honghua Li, Sunny Steiner, Deborah Yan, Tina Arbet-Engels, Christophe Associate Professor of Medicine Rheumatology and Immunology/Division of Rheumatology and Immunology Department of Medicine Duke University Durham NC USA Full Professor of Pediatrics Chair of Pediatrics ASST Spedali Civili Brescia/Department of Clinical and Experimental Sciences University of Brescia & ASST Spedali Civili Brescia Italy Pediatric Physician/CHU Paris Est - Hôpital d’Enfants Armand-Trousseau Paris France Senior Director Pharmacovigilance & Risk Management/X4 Pharmaceuticals Boston MA USA Director Clinical Research/X4 Pharmaceuticals Boston MA USA Senior Director Biostatistics/X4 Pharmaceuticals Boston MA USA Senior Director Statistical Programming/X4 Pharmaceuticals Boston MA USA Vice President Clinical Development/X4 Pharmaceuticals Boston MA USA Director Statistical Programming/X4 Pharmaceuticals Boston MA USA Chief Medical Officer/X4 Pharmaceuticals Boston MA USA
来源: 评论
POS1050 INCIDENCE RATES OF INTERSTITIAL LUNG DISEASE AMONG PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH ABATACEPT: A POST HOC POOLED ANALYSIS FROM A COMPENDIUM OF CLINICAL TRIALS
收藏 引用
Annals of the Rheumatic Diseases 2023年 82卷 843-843页
作者: P. Dieudé J. Sparks A. Fischer L. Chen K. Lozenski S. Dahan M. Chaballa W. Little Paris Cité University Bichat Hospital APHP Department of Rheumatology Paris France Brigham and Women's Hospital Harvard Medical School Division of Rheumatology Inflammation and Immunity Boston United States of America Bristol Myers Squibb Lung Fibrosis Lawrenceville United States of America Syneos Health Biostatistics and Statistical Programming Richmond Canada Bristol Myers Squibb Rheumatology Pipeline and Early Assets Lawrenceville United States of America Bristol Myers Squibb Worldwide Medical Lawrenceville United States of America Bristol Myers Squibb US Medical Immunology and Fibrosis Lawrenceville United States of America Bristol Myers Squibb Worldwide Rheumatology Lawrenceville United States of America
Background Interstitial lung disease (ILD) is a recognized complication of RA. Prior studies have suggested stabilization or improvement of ILD in patients with RA (RA-ILD) treated with abatacept. [1,2] Few studies ha...
来源: 评论
VP6-2022: Adjuvant pertuzumab and trastuzumab in patients with early HER-2 positive breast cancer in APHINITY: 8.4 years' follow-up
收藏 引用
Annals of Oncology 2022年 第9期33卷 986-987页
作者: S. Loibl J. Jassem A. Sonnenblick D. Parlier E. Winer J. Bergh R.D. Gelber E. Restuccia Y-H. Im C. Huang F. Dalenc I. Calvo M. Procter C. Caballero E. Clark H.L. Gomez Moreno J. Bliss G. Viale J. Bines M. Piccart Medicine and Research Dept. German Breast Group (GBG) Forschungs GmbH Neu-Isenburg Germany Oncology & Radiotherapy Medical University of Gdansk Gdansk Poland Oncology Department Tel Aviv Sourasky Medical Center-(Ichilov) Tel Aviv Israel Clinical Trials Support Unit Institut Jules Bordet Brussels Belgium Yale Cancer Center Yale University School of Medicine - Yale Cancer Center New Haven CT USA Department of Oncology-Pathology Karolinska Institutet and Breast Cancer Centre Cancer Theme Karolinska University Hospital Stockholm Sweden Biostatistics Dana Farber Cancer Institute Boston MA USA Product Development Oncology F. Hoffmann-La Roche Ltd Basel Switzerland Medicine Dept. Hematology/Medical Oncology Division Samsung Medical Center (SMC) - Sungkyunkwan University School of Medicine Seoul Republic of Korea Surgery Dept. NTUH - National Taiwan University Hospital Taipei Taiwan Oncologie 1A Institut Universitaire du Cancer Toulouse - Oncopole Toulouse France Breast Cancer Unit MD Anderson Cancer Center Madrid Madrid Spain Statistics and Programming Frontier Science Scotland Kincraig UK Medical Department Breast International Group (BIG) - AISBL Brussels Belgium Data Sciences - Data & Statistical Sciences (DSS) Roche Products Limited Welwyn Garden City UK Medicine Department INEN - Instituto Nacional de Enfermedades Neoplasicas Lima Peru Clinical Trials and Statistics Unit ICR - Institute of Cancer Research London UK Department of Oncology Università degli Studi di Milano Milan Italy Medical Oncology Department Instituto Nacional de Cancer - Research Center Rio de Janeiro Brazil Institut Jules Bordet Brussels Belgium
来源: 评论